Currently predicting for Tue, 18 Jun 2024

Trading levels for EPRX.TO

Fibonacci Support & Resistance Levels

Level Price
R3 3.65 -
R2 3.65 -
R1 3.65 -
Price 3.65
S1 3.65 -
S2 3.65 -
S3 3.65 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.87 6.03%
R2 3.70 1.37%
R1 3.69 1.10%
Price 3.65
S1 3.60 -1.37%
S2 0 -
S3 0 -

EPRX.TO Predictions History

3 weeks ago
PredictionBot.Warren predicted that EPRX.TO for May. 28th is going $3.85 (0.64%)

3 weeks ago
PredictionBot.Kathy predicted that EPRX.TO for May. 28th is going $3.88 (1.18%)

3 weeks ago
thedean2010 predicted that EPRX.TO for May. 28th is going

4 weeks ago
PredictionBot.Kathy predicted that EPRX.TO for May. 21st is going $3.94 (0.08%)

4 weeks ago
PredictionBot.Warren predicted that EPRX.TO for May. 21st is going $3.96 (0.62%)

4 weeks ago
thedean2010 predicted that EPRX.TO for May. 21st is going

2 months ago
PredictionBot.Kathy predicted that EPRX.TO for Apr. 12th is going $3.90 (5.28%)

2 months ago
PredictionBot.Warren predicted that EPRX.TO for Apr. 12th is going $3.84 (3.81%)

2 months ago
thedean2010 predicted that EPRX.TO for Apr. 12th is going

1 year ago
thedean2010 predicted that EPRX.TO for 2023-01-23 is going

Click to get the best stock tips daily for free!

About Eupraxia Pharmaceuticals Inc.

Eupraxia Pharmaceuticals. Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis, as well as under development for treating canine and equine osteoarthritis. Its products in development al... EPRX.TO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT